Selective aortic arch perfusion
US5437633A · kind A · utility
93Cited by
5References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 30, 1994 |
| Grant date | Aug 1, 1995 |
| Priority date | — |
| Expiry date | Mar 30, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2210/125
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A method of treating a subject in cardiac arrest, comprises blocking the descending aorta of the subject and then perfusing the aortic arch of the subject with a protective solution. The protective solution is one capable of delivering oxygen to the heart of said subject, such-as a perfluorochemical blood substitute. Following perfusion, spontaneous circulation is restored. In an improved embodiment of the foregoing, a vasoconstrictor such as epinephrine is administered concurrently with the perfusing step in an amount effective to enhance coronary perfusion with said protective solution.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.